| MDedge | MDedge

Article

Metformin ups gastrointestinal adverse event risk in T2D

Publish date: October 23, 2022

Read More

Article

Metformin may offer more neuroprotection for dementia than sulfonylurea in T2D

Publish date: October 23, 2022

Read More

Article

Saxagliptin add-on to oral antihyperglycemic agents safe and effective in drug-naive T2D patients

Publish date: October 23, 2022

Read More

Article

T2D: Bexagliflozin add-on to metformin shows antidiabetic potency equivalent to glimepiride

Publish date: October 23, 2022

Read More

Article

T2D: Increased risk for ventricular arrhythmia or sudden cardiac death with sulfonylurea vs metformin

Publish date: October 23, 2022

Read More

Article

Antidiabetic drugs influence fracture risk in T2D

Publish date: October 23, 2022

Read More

Article

Tirzepatide vs. insulin glargine improves renal outcomes in T2D

Publish date: October 23, 2022

Read More

Article

Meta-analysis evaluates safety and efficacy of cinnarizine in migraine

Publish date: October 23, 2022

Read More

Article

Risk for inpatient constipation similar with erenumab and other anti-CGRP mAb in migraine

Publish date: October 23, 2022

Read More

Article

Preventive treatment improves cognition and QoL in patients with chronic migraine

Publish date: October 23, 2022

Read More

Pages